These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6203310)

  • 1. Improvement of progressive systemic sclerosis (PSS) with estriol treatment.
    Katayama H; Ohsawa K; Yaoita H
    Acta Derm Venereol; 1984; 64(2):168-71. PubMed ID: 6203310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen in the esophageal mucosa of patients with progressive systemic sclerosis (PSS).
    Hendel L; Ammitzbøll T; Dirksen K; Petri M
    Acta Derm Venereol; 1984; 64(6):480-4. PubMed ID: 6084918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma (progressive systemic sclerosis, PSS); pathophysiological, clinical and pharmacological aspects of the syndrome.
    Herbai G
    Acta Med Acad Sci Hung; 1978; 35(3-4):201-11. PubMed ID: 756110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
    Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
    J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis.
    Knobler RM; French LE; Kim Y; Bisaccia E; Graninger W; Nahavandi H; Strobl FJ; Keystone E; Mehlmauer M; Rook AH; Braverman I;
    J Am Acad Dermatol; 2006 May; 54(5):793-9. PubMed ID: 16635659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive systemic sclerosis and penicillamine.
    Rodnan GP
    J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatments of progressive systemic sclerosis].
    Vayssairat M; Abdoucheli-Baudot N; Gaitz JP
    J Mal Vasc; 2001 Oct; 26(4):258-61. PubMed ID: 11679856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment].
    Watanabe S; Sugihara T; Takahashi M; Ata K; Kanzaki A; Yamada O; Yawata Y
    Rinsho Ketsueki; 1994 Sep; 35(9):895-7. PubMed ID: 7967060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.
    Buckingham RB; Prince RK; Rodnan GP
    J Lab Clin Med; 1983 May; 101(5):659-69. PubMed ID: 6833837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global improvement of systemic scleroderma under long-term administration of octreotide.
    Descamps V; Duval X; Crickx B; Bouscarat F; Coffin B; Belaich S
    Eur J Dermatol; 1999 Sep; 9(6):446-8. PubMed ID: 10491499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen V nasal tolerance in experimental model of systemic sclerosis.
    Velosa AP; Teodoro WR; de Oliveira CC; Dos Santos Filho A; Moutinho RF; Santos AG; Vendramini MB; Bueno C; Parra ER; Capelozzi VL; Yoshinari NH
    Arch Dermatol Res; 2007 Jul; 299(4):177-89. PubMed ID: 17297604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen components in the duodenal and rectal mucosa in progressive systemic sclerosis and other diseases.
    Hendel L; Ammitzbøll T; Dirksen K; Petri M
    Acta Derm Venereol; 1986; 66(3):220-4. PubMed ID: 2426898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of patients affected by systemic sclerosis with cyclosporin A.
    Basso M; Filaci G; Cutolo M; Murdaca G; Derchi L; Gianrossi R; Ropolo F; Zentilin P; Sulli A; Puppo F; Indiveri F
    Ann Ital Med Int; 2001; 16(4):233-9. PubMed ID: 11799631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [mRNA expression of procollagen and SMADs in lesional skin of progressive systemic sclerosis].
    Yu HY; Li H; Chen DF; Cheng H
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):546-9. PubMed ID: 17459205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclofenil in the treatment of scleroderma - a general view on the results after treating 29 cases.
    Bülow BB; Boström H; Herbai G; Persson B; Wollheim F; Oberg K
    Z Rheumatol; 1980; 39(1-2):1-8. PubMed ID: 7424193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is imatinib mesylate a promising drug in systemic sclerosis?
    van Daele PL; Dik WA; Thio HB; van Hal PT; van Laar JA; Hooijkaas H; van Hagen PM
    Arthritis Rheum; 2008 Aug; 58(8):2549-52. PubMed ID: 18668570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of systemic sclerosis with topical PUVA.
    Morita A; Sakakibara S; Sakakibara N; Yamauchi R; Tsuji T
    J Rheumatol; 1995 Dec; 22(12):2361-5. PubMed ID: 8835578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue in skin biopsies from patients suffering systemic sclerosis.
    Quaglino D; Bergamini G; Boraldi F; Manzini E; Davidson JM; Pasquali Ronchetti I
    J Submicrosc Cytol Pathol; 1996 Apr; 28(2):287-96. PubMed ID: 8964053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural changes induced in cutaneous collagen by ultraviolet-A1 and psoralen plus ultraviolet A therapy in systemic sclerosis.
    Sakakibara N; Sugano S; Morita A
    J Dermatol; 2008 Feb; 35(2):63-9. PubMed ID: 18271800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.